Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 3 1Phase 1/2 1

Status

Recruiting 2Completed 1Active not recruiting 1

Sponsor Class

OTHER 3NETWORK 1

Study Type

Interventional 3Observational 1

Sponsor

Cancer Type

Lymphoid 10Other hematologic neoplasm 4Breast 4Genitourinary 2Thoracic 1Sarcoma 1Gastrointestinal 1CNS 1

Conditions

Breast Neoplasms 3Triple Negative Breast Neoplasms 1Pain 1Inflammatory Breast Neoplasms 1

Interventions

Fulvestrant 81Letrozole 74Paclitaxel 71pembrolizumab 67Specimen Handling 63Trastuzumab 60Carboplatin 55Magnetic Resonance Spectroscopy 50ribociclib 47Capecitabine 47Anastrozole 45palbociclib 44pertuzumab 43Tamoxifen 38Cyclophosphamide 38exemestane 37abemaciclib 37Biopsy 35trastuzumab deruxtecan 30Docetaxel 28Taxes 27Gemcitabine 25Radiotherapy 24Surveys and Questionnaires 23130-nm albumin-bound paclitaxel 23Standard of Care 21Blood Specimen Collection 21sacituzumab govitecan 20olaparib 20eribulin 18

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
pegfilgrastim × Breast × 90 days × Clear all
NCT04174742 2026-05-26

Self Reported Pain in Women While Undergoing Treatment for Non-metastatic Breast Cancer

Wake Forest University Health Sciences

Recruiting
115 enrolled
Breast

Breast Neoplasms, Pain

NCT00433420 2026-04-30

Combination Chemotherapy With or Without Fluorouracil and/or Pegfilgrastim in Treating Women With Node-Positive Breast Cancer

IRCCS Azienda Ospedaliera Universitaria San Martino - IST Istituto Nazionale per la Ricerca sul Cancro, Genoa, Italy

Phase 3 Active not recruiting
2,000 enrolled
Breast

Breast Neoplasms

NCT07525869 2026-04-20

An Open-label Prospective Study to Evaluate the Efficacy and Safety of Pegfilgrastim in Triple-Negative Breast Cancer Patients Receiving AC Regimen Following Paclitaxel and Carboplatin as Neoadjuvant Therapy

Yonsei University

Phase NA Recruiting
40 enrolled
Breast

Triple Negative Breast Neoplasms

NCT00066443 2026-03-27

Epirubicin, Docetaxel, and Pegfilgrastim in Treating Women With Locally Advanced or Inflammatory Breast Cancer

Canadian Cancer Trials Group

Phase 1/2 Completed
93 enrolled
Breast

Breast Neoplasms, Inflammatory Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡